Identifying the 5 Stages of Addiction Addiction to drugs or alcohol occu...
In a historic 14-to-2 vote the FDA has approved Janssen Pharmaceuticals new medication, Spravato, for clinical depression.
Back in May of 2018, the FDA approved Lucemyra, a new medication to treat the symptoms of opioid withdrawal. It is available as of August of 2018.
Knowing how to tell the difference between good rehab advertising and shady practices can be life-saving for an individual suffering from addiction.
Back in June, the FDA approved Epidiolex as the first marijuana-based medication in the United States. As of November, it is available across the U.S.
On October 3rd, 2018, the Senate passed an opioid package that contained several bills that have all faced contention in the past.
Demi Lovato’s recent relapse in her enduring battle with addiction and depression emphasizes the need for continuing treatment and a network of vigilance.